Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.

@article{Raval2017ManagementOP,
  title={Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.},
  author={Amish N. Raval and Joaquin E. Cigarroa and Mina K. Chung and Larry J. Diaz-Sandoval and Deborah B. Diercks and Jonathan P Piccini and Hee Soo Jung and Jeffrey B. Washam and Babu G. Welch and Allyson R. Zazulia and Sean Patrick Collins},
  journal={Circulation},
  year={2017},
  volume={135 10},
  pages={e604-e633}
}
Non-vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin for stroke prevention in atrial fibrillation and management of venous thromboembolism. In clinical practice, there is still widespread uncertainty on how to manage patients on NOACs who bleed or who are at risk for bleeding. Clinical trial data related to NOAC reversal for bleeding and perioperative management are sparse, and recommendations are largely derived from expert opinion. Knowledge of time of… CONTINUE READING
14 Citations
164 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 164 references

http://ciajournals.org/ D ow nladed from Raval et al TBD, 2017 Circulation

  • TG Jovin, A Chamorro, +9 authors X Urra
  • Sptem er 16,
  • 2017

ANNEXA-4 Investigators. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors

  • SJ Connolly, TJ JrMilling, +22 authors M Crowther
  • N Engl J Med. 2016;375:1131–1141. doi: 10.1056…
  • 2016

Similar Papers

Loading similar papers…